# Correction: Synthesis, characterization, DNA interaction, and anticancer studies of novel facial tricarbonylrhenium(i) complexes with uracil-derived ligands

**Authors:** Shabaaz Abdullah, Candace Davison, Christie Jane Smit, Phiwokuhle Mbatha, Jo-Anne de la Mare, Irvin Noel Booysen

PMC · DOI: 10.1039/d5ra90121a · 2025-10-27

## TL;DR

This paper corrects a previously published study on new rhenium complexes with potential anticancer properties.

## Contribution

The paper provides a correction to prior research on facial tricarbonylrhenium(i) complexes with uracil-derived ligands.

## Key findings

- The correction addresses errors in the original publication.
- It ensures accurate synthesis and characterization details of the rhenium complexes.

## Abstract

Correction for ‘Synthesis, characterization, DNA interaction, and anticancer studies of novel facial tricarbonylrhenium(i) complexes with uracil-derived ligands’ by Shabaaz Abdullah et al., RSC Adv., 2025, 15, 34635–34642, https://doi.org/10.1039/D5RA05387K.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Chemicals:** tricarbonylrhenium(i) (-), uracil (MESH:D014498)

---
Source: https://tomesphere.com/paper/PMC12557327